Clinical Trials Browser

Phase 2 × Solid Tumors × Afatinib × Clear all

NCT02506517 2023-08-01

A Study of Afatinib in Patients With Advanced Cancer With Changes in the HER Gene

Phase 2 Completed

Other solid neoplasm

Solid Tumors